Attached files
file | filename |
---|---|
EX-3.1 - EX-3.1 - Alexza Pharmaceuticals Inc. | f59706exv3w1.htm |
EX-3.2 - EX-3.2 - Alexza Pharmaceuticals Inc. | f59706exv3w2.htm |
EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc. | f59706exv31w2.htm |
EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc. | f59706exv31w1.htm |
EXCEL - IDEA: XBRL DOCUMENT - Alexza Pharmaceuticals Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - Alexza Pharmaceuticals Inc. | f59706e10vq.htm |
EXHIBIT 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of
1934, as amended (the Exchange Act), and Section 1350 of Chapter 63 of Title 18 of the United
States Code (18 U.S.C. § 1350), Thomas B. King, President and Chief Executive Officer of Alexza
Pharmaceuticals, Inc. (the Company), and August J. Moretti, Senior Vice President, Chief
Financial Officer, General Counsel, and Secretary of the Company, each hereby certifies that, to
the best of his knowledge:
1. The Companys Quarterly Report on Form 10-Q for the period ended June 30, 2011, to which this
Certification is attached as Exhibit 32.1 (the Periodic Report), fully complies with the
requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2. The information contained in the Periodic Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 8th day of August
2011.
/s/ Thomas B. King
|
/s/ August J. Moretti | |
Thomas B. King President and Chief Executive Officer |
August J. Moretti Senior Vice President, Chief Financial Officer, General Counsel and Secretary |
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not to be incorporated by reference into any filing of
Alexza Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities
Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q),
irrespective of any general incorporation language contained in such filing.
53